|
HSPA14 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.36300029227743E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.69610000488873E-08 |
| Normal-vs-Stage2 |
2.962100E-03 |
| Normal-vs-Stage3 |
2.35429999999592E-05 |
| Normal-vs-Stage4 |
2.800700E-03 |
| Stage1-vs-Stage2 |
9.361800E-01 |
| Stage1-vs-Stage3 |
9.876600E-01 |
| Stage1-vs-Stage4 |
5.639200E-01 |
| Stage2-vs-Stage3 |
9.394800E-01 |
| Stage2-vs-Stage4 |
6.724600E-01 |
| Stage3-vs-Stage4 |
5.843000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.91229970431573E-10 |
| Normal-vs-AfricanAmerican |
2.201700E-02 |
| Normal-vs-Asian |
3.161300E-03 |
| Caucasian-vs-AfricanAmerican |
9.770400E-02 |
| Caucasian-vs-Asian |
8.146200E-01 |
| AfricanAmerican-vs-Asian |
3.379000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.37990000046184E-07 |
| Normal-vs-Female |
1.27199994981453E-09 |
| Male-vs-Female |
1.122050E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.389200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.12209999958424E-07 |
| Normal-vs-Age(61-80Yrs) |
1.92909999974233E-07 |
| Normal-vs-Age(81-100Yrs) |
3.836800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.811600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.764200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.053600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.691000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.162600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.836390E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.436400E-03 |
| Normal-vs-Grade 2 |
9.68329971762216E-10 |
| Normal-vs-Grade 3 |
1.04089999997115E-06 |
| Normal-vs-Grade 4 |
3.267800E-02 |
| Grade 1-vs-Grade 2 |
4.761400E-01 |
| Grade 1-vs-Grade 3 |
1.799180E-01 |
| Grade 1-vs-Grade 4 |
2.175400E-01 |
| Grade 2-vs-Grade 3 |
1.411840E-01 |
| Grade 2-vs-Grade 4 |
4.675000E-01 |
| Grade 3-vs-Grade 4 |
9.772600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.2632564145606E-12 |
| Normal-vs-ccB subtype |
1.199820E-03 |
| ccA subtype-vs-ccB subtype |
2.199800E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.1735000011478E-08 |
| Normal-vs-N1 |
1.648430E-01 |
| N0-vs-N1 |
8.383400E-01 |
|
|
